Home | Sitemap | Search | Contact A- A A+
   
 
    Public Member Support us  
 

IBCSG 21-99 

Menstrual cycle and surgical treatment of breast cancer

DESIGN

Design Trial 21-99

Study Chair
Prof. Richard Gelber - Boston, USA

Trial Coordinators
Holly Shaw

IBCSG Data Management Center/FSTRF
4033 Maple Road
Amherst, New York 14226 USA
Phone: +1 716 834 0900
Fax: +1 716 836 6097
Email: ibcsg21@fstrf.org


Date of Activation (IBCSG)
November 26, 1999

Date of Closure
December 31, 2001

Targeted Accrual
1100 patients

Final Accrual
1118 patients
IBCSG: 159
NCCTG: 184
NSABP: 775



News

18.12.2014:
New publications are available 

11.12.2014:
San Antonio Breast Cancer Symposium 2014: IBCSG Presents SOFT Results.

10.12.2014:
IBCSG and Merck Announce Opening of International PANACEA Study of Patients with HER2+ Breast

All News

 
  Print